DOPAMINE SIGNALING AND THE SMALL G PROTEIN RHES

$156,643P20FY2010RRNIH

Lsu Health Sciences Center, New Orleans LA

Investigators

Linked publications & trials

Paper 31595490 Paper 25120437 Paper 24693964 Paper 24011821 Paper 23531884 Paper 23380860 Paper 23380502 Paper 23344947 Paper 23322446 Paper 23154943 Paper 23136427 Paper 22535448 Paper 22511762 Paper 22450871 Paper 22136696 Paper 21957234 Paper 21854772 Paper 21817052 Paper 21811239 Paper 21756134 Paper 21606111 Paper 21569016 Paper 21374700 Paper 21246057 Paper 21220563 Paper 21204830 Paper 21163334 Paper 21146591 Paper 21056634 Paper 21035444 Paper 20573774 Paper 20559640 Paper 20382842 Paper 20238071 Paper 20181788 Paper 20095043 Paper 19931440 Paper 19520558 Paper 19403949 Paper 19375287 Paper 19240036 Paper 19110036 Paper 19070599 Paper 19018037 Paper 19012750 Paper 18929545 Paper 18845937 Paper 18778753 Paper 18638539 Paper 18560209 Paper 18541382 Paper 18537667 Paper 18322006 Paper 18295507 Paper 18188926 Paper 18060755 Paper 18000827 Paper 17962433 Paper 17855590 Paper 17670936 Paper 17670935 Paper 17460080 Paper 17318881 Paper 17285000 Paper 17272353 Paper 17249620 Paper 17077143 Paper 16957004 Paper 16899724 Paper 16899074 Paper 16775153 Paper 16546297 Paper 16519477 Paper 16392040 Paper 16376302 Paper 16352400 Paper 16289381 Paper 16251433 Paper 16239276 Paper 16187219 Paper 16151530 Paper 16137646 Paper 16099392 Paper 16079394 Paper 16056137 Paper 15994343 Paper 15987952 Paper 15854773 Paper 15653788 Paper 15360283 Paper 15296851 Paper 15264222 Paper 15152078 Paper 15106842 Paper 14984414 Paper 14663208 Paper 14519523 Paper 13130128 Paper 12923200 Paper 12692475

Abstract

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Specific Aim (1) To test the prediction that Rhes inhibits dopamine-mediated intracellular signaling. Specific Aim (2) To test the prediction that directly and specifically decreasing Rhes expression in vivo will result in supersensitive dopamine-mediated signaling and motor behavior. Specific Aim (3) To test the prediction that alterations in dopamine transmission affect Rhes expression. The specific aims have not been modified.

View original record on NIH RePORTER →